New Drugs from Marine Organisms in Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Current approved drugs may only ameliorate symptoms in a restricted number of patients and for a restricted period of time. Currently, there is a translational research challenge into identifying the new effective drugs and the...

Full description

Bibliographic Details
Main Authors: Patrizia Russo, Aliaksei Kisialiou, Palma Lamonaca, Rossana Moroni, Giulia Prinzi, Massimo Fini
Format: Article
Language:English
Published: MDPI AG 2015-12-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/14/1/5